---

TACROLIMUS IN OPHTHALMOLOGY

---

Review Article

Author Details : Abdul Waris, G K Nagpal, Gargi Nagpal, Naheed Akhtar

Volume : 1, Issue : 1, Year : 2015

Article Page : 3-6

Suggest article by email

Get Permission

---

Abstract

Tacrolimus is a 23 member cyclic macrolide lactone and was isolated from Streptomyces tsukubaensis in 1984.[1] it has been shown in vitro and in vivo to be a potent immunosuppressive agent. It is 100 times more powerful than cyclosporine in vitro in inhibiting T-cell proliferative responses, including mixed lymphocyte reactivity and cytotoxic T-cell generation. This immunomodulator has increasing number of implications in various aspects of ophthalmological conditions, the battle against them so far having been fought with corticosteroids, which are themselves a double edged sword. In this article we will be going through various studies which have thrown light on the future potential of applications of tacrolimus in ophthalmology.[2]

Key Words: allergic conjunctivitis, dry eye disease, tacrolimus, immunomodulation, uveitis, graft versus host disease

How to cite : Waris A, Nagpal G K, Nagpal G, Akhtar N, TACROLIMUS IN OPHTHALMOLOGY. Indian J Clin Exp Ophthalmol 2015;1(1):3-6

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.